Molecular diversity and its analysis

We have recently developed a novel strategy for the rational design of compounds. This ‘ in silico screening’ approach is based on the design and screening of virtual combinatorial libraries. Screening is performed using defined rules derived from a comprehensive description of active and inactive m...

Full description

Saved in:
Bibliographic Details
Published in:Drug Discovery Today 1999-06, Vol.4 (6), p.257-264
Main Authors: Gorse, Dominique, Rees, Anthony, Kaczorek, Michel, Lahana, Roger
Format: Article
Language:English
Subjects:
Biological and medical sciences
General pharmacology
Medical sciences
Molecular diversity
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Rational drug design
Virtual combinatorial chemistry
Virtual screening
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c423t-e77927dd044365c35ad8a4dc53ac358d3ea1dcaaaf73b5e76ca2ce0ccd400c973
cites
container_end_page 264
container_issue 6
container_start_page 257
container_title Drug Discovery Today
container_volume 4
creator Gorse, Dominique
Rees, Anthony
Kaczorek, Michel
Lahana, Roger
description We have recently developed a novel strategy for the rational design of compounds. This ‘ in silico screening’ approach is based on the design and screening of virtual combinatorial libraries. Screening is performed using defined rules derived from a comprehensive description of active and inactive molecules in a relevant learning set. This strategy allows the development of potential ligands without the necessity of any knowledge of the 3D-structure of the target receptor. Key to the success of such methods is the quality of the information being processed, in particular, the diversity of the data in the context of the molecular population in the libraries concerned. Here, we review the problem of data diversity, its definition and its analysis using a new software tool, named Diverser.
doi_str_mv 10.1016/S1359-6446(99)01334-3
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1859306941</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1359644699013343</els_id><sourcerecordid>1859306941</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-e77927dd044365c35ad8a4dc53ac358d3ea1dcaaaf73b5e76ca2ce0ccd400c973</originalsourceid><addsrcrecordid>eNqFkEtLAzEQgIMovn-C0kORelhNNo_dnESKL6h4UM9hnEwhsu3WZFvovze2FT3paWbgm9fH2IngF4ILc_kspLaFUcoMrD3nQkpVyC22L-qqLnQty-2cfyN77CCld85FabXZZXuCS6204vus_9g2hPMGYs-HBcUUumUPpr4XupQjNMsU0hHbGUOT6HgTD9nr7c3L8L4YPd09DK9HBapSdgVVlS0r77lS0miUGnwNyqOWkIvaSwLhEQDGlXzTVBmEEokjesU52koessF67iy2H3NKnZuEhNQ0MKV2npyotZXcWCUyevY3Wqn8rTEZ1GsQY5tSpLGbxTCBuHSCuy-TbmXSfWly1rqVSSdz3-lmwfxtQv5X11pdBvobABJCM44wxZB-uForKWzGrtYYZXGLQNElDDRF8iESds634Z9LPgGO6I6R</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17401266</pqid></control><display><type>article</type><title>Molecular diversity and its analysis</title><source>Elsevier</source><creator>Gorse, Dominique ; Rees, Anthony ; Kaczorek, Michel ; Lahana, Roger</creator><creatorcontrib>Gorse, Dominique ; Rees, Anthony ; Kaczorek, Michel ; Lahana, Roger</creatorcontrib><description>We have recently developed a novel strategy for the rational design of compounds. This ‘ in silico screening’ approach is based on the design and screening of virtual combinatorial libraries. Screening is performed using defined rules derived from a comprehensive description of active and inactive molecules in a relevant learning set. This strategy allows the development of potential ligands without the necessity of any knowledge of the 3D-structure of the target receptor. Key to the success of such methods is the quality of the information being processed, in particular, the diversity of the data in the context of the molecular population in the libraries concerned. Here, we review the problem of data diversity, its definition and its analysis using a new software tool, named Diverser.</description><identifier>ISSN: 1359-6446</identifier><identifier>EISSN: 1878-5832</identifier><identifier>DOI: 10.1016/S1359-6446(99)01334-3</identifier><identifier>PMID: 10354540</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Biological and medical sciences ; General pharmacology ; Medical sciences ; Molecular diversity ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Rational drug design ; Virtual combinatorial chemistry ; Virtual screening</subject><ispartof>Drug Discovery Today, 1999-06, Vol.4 (6), p.257-264</ispartof><rights>1999 Elsevier Science Ltd</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-e77927dd044365c35ad8a4dc53ac358d3ea1dcaaaf73b5e76ca2ce0ccd400c973</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>313,314,780,784,792,27922,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1854319$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10354540$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gorse, Dominique</creatorcontrib><creatorcontrib>Rees, Anthony</creatorcontrib><creatorcontrib>Kaczorek, Michel</creatorcontrib><creatorcontrib>Lahana, Roger</creatorcontrib><title>Molecular diversity and its analysis</title><title>Drug Discovery Today</title><addtitle>Drug Discov Today</addtitle><description>We have recently developed a novel strategy for the rational design of compounds. This ‘ in silico screening’ approach is based on the design and screening of virtual combinatorial libraries. Screening is performed using defined rules derived from a comprehensive description of active and inactive molecules in a relevant learning set. This strategy allows the development of potential ligands without the necessity of any knowledge of the 3D-structure of the target receptor. Key to the success of such methods is the quality of the information being processed, in particular, the diversity of the data in the context of the molecular population in the libraries concerned. Here, we review the problem of data diversity, its definition and its analysis using a new software tool, named Diverser.</description><subject>Biological and medical sciences</subject><subject>General pharmacology</subject><subject>Medical sciences</subject><subject>Molecular diversity</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Rational drug design</subject><subject>Virtual combinatorial chemistry</subject><subject>Virtual screening</subject><issn>1359-6446</issn><issn>1878-5832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqFkEtLAzEQgIMovn-C0kORelhNNo_dnESKL6h4UM9hnEwhsu3WZFvovze2FT3paWbgm9fH2IngF4ILc_kspLaFUcoMrD3nQkpVyC22L-qqLnQty-2cfyN77CCld85FabXZZXuCS6204vus_9g2hPMGYs-HBcUUumUPpr4XupQjNMsU0hHbGUOT6HgTD9nr7c3L8L4YPd09DK9HBapSdgVVlS0r77lS0miUGnwNyqOWkIvaSwLhEQDGlXzTVBmEEokjesU52koessF67iy2H3NKnZuEhNQ0MKV2npyotZXcWCUyevY3Wqn8rTEZ1GsQY5tSpLGbxTCBuHSCuy-TbmXSfWly1rqVSSdz3-lmwfxtQv5X11pdBvobABJCM44wxZB-uForKWzGrtYYZXGLQNElDDRF8iESds634Z9LPgGO6I6R</recordid><startdate>19990601</startdate><enddate>19990601</enddate><creator>Gorse, Dominique</creator><creator>Rees, Anthony</creator><creator>Kaczorek, Michel</creator><creator>Lahana, Roger</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19990601</creationdate><title>Molecular diversity and its analysis</title><author>Gorse, Dominique ; Rees, Anthony ; Kaczorek, Michel ; Lahana, Roger</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-e77927dd044365c35ad8a4dc53ac358d3ea1dcaaaf73b5e76ca2ce0ccd400c973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Biological and medical sciences</topic><topic>General pharmacology</topic><topic>Medical sciences</topic><topic>Molecular diversity</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Rational drug design</topic><topic>Virtual combinatorial chemistry</topic><topic>Virtual screening</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gorse, Dominique</creatorcontrib><creatorcontrib>Rees, Anthony</creatorcontrib><creatorcontrib>Kaczorek, Michel</creatorcontrib><creatorcontrib>Lahana, Roger</creatorcontrib><collection>Pascal-Francis</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Drug Discovery Today</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gorse, Dominique</au><au>Rees, Anthony</au><au>Kaczorek, Michel</au><au>Lahana, Roger</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular diversity and its analysis</atitle><jtitle>Drug Discovery Today</jtitle><addtitle>Drug Discov Today</addtitle><date>1999-06-01</date><risdate>1999</risdate><volume>4</volume><issue>6</issue><spage>257</spage><epage>264</epage><pages>257-264</pages><issn>1359-6446</issn><eissn>1878-5832</eissn><abstract>We have recently developed a novel strategy for the rational design of compounds. This ‘ in silico screening’ approach is based on the design and screening of virtual combinatorial libraries. Screening is performed using defined rules derived from a comprehensive description of active and inactive molecules in a relevant learning set. This strategy allows the development of potential ligands without the necessity of any knowledge of the 3D-structure of the target receptor. Key to the success of such methods is the quality of the information being processed, in particular, the diversity of the data in the context of the molecular population in the libraries concerned. Here, we review the problem of data diversity, its definition and its analysis using a new software tool, named Diverser.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>10354540</pmid><doi>10.1016/S1359-6446(99)01334-3</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1359-6446
ispartof Drug Discovery Today, 1999-06, Vol.4 (6), p.257-264
issn 1359-6446
1878-5832
language eng
recordid cdi_proquest_miscellaneous_1859306941
source Elsevier
subjects Biological and medical sciences
General pharmacology
Medical sciences
Molecular diversity
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Rational drug design
Virtual combinatorial chemistry
Virtual screening
title Molecular diversity and its analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T12%3A38%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20diversity%20and%20its%20analysis&rft.jtitle=Drug%20Discovery%20Today&rft.au=Gorse,%20Dominique&rft.date=1999-06-01&rft.volume=4&rft.issue=6&rft.spage=257&rft.epage=264&rft.pages=257-264&rft.issn=1359-6446&rft.eissn=1878-5832&rft_id=info:doi/10.1016/S1359-6446(99)01334-3&rft_dat=%3Cproquest_cross%3E1859306941%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c423t-e77927dd044365c35ad8a4dc53ac358d3ea1dcaaaf73b5e76ca2ce0ccd400c973%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17401266&rft_id=info:pmid/10354540&rfr_iscdi=true